PT Sejahteraraya Anugrahjaya Tbk operates hospitals and offers health care services. It operates and offers medical centers, which include neuroscience, Uro-nephrology, obstetrics and gynecology, cardiovascular, orthopedic, pediatric, oncology, immunology, pulmonology, and internal medicine. The company's business segments are Inpatient, and outpatients for patients, of which prime revenue is derived from the Inpatient segment. Group is divided into four geographical areas: namely DKI Jakarta, Banten, West Java, and East Java.
1991
4.1K+
Last FY Revenue $193M
Last FY EBITDA $15.6M
$2.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Mayapada Hospital achieved revenue of $193M and an EBITDA of $15.6M.
Mayapada Hospital expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Mayapada Hospital valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $193M | XXX | XXX | XXX |
Gross Profit | XXX | $56.2M | XXX | XXX | XXX |
Gross Margin | XXX | 29% | XXX | XXX | XXX |
EBITDA | XXX | $15.6M | XXX | XXX | XXX |
EBITDA Margin | XXX | 8% | XXX | XXX | XXX |
EBIT | XXX | $10.5M | XXX | XXX | XXX |
EBIT Margin | XXX | 5% | XXX | XXX | XXX |
Net Profit | XXX | -$1.4M | XXX | XXX | XXX |
Net Margin | XXX | -1% | XXX | XXX | XXX |
Net Debt | XXX | $85.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Mayapada Hospital's stock price is IDR 3000 (or $0).
Mayapada Hospital has current market cap of IDR 36.72T (or $2.3B), and EV of IDR 39.05T (or $2.4B).
See Mayapada Hospital trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.4B | $2.3B | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Mayapada Hospital has market cap of $2.3B and EV of $2.4B.
Mayapada Hospital's trades at 12.4x EV/Revenue multiple, and 153.9x EV/EBITDA.
Equity research analysts estimate Mayapada Hospital's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mayapada Hospital's P/E ratio is not available.
See valuation multiples for Mayapada Hospital and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $2.3B | XXX | $2.3B | XXX | XXX | XXX |
EV (current) | $2.4B | XXX | $2.4B | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 12.4x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | 153.9x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | 228.6x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -1561.6x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -150.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMayapada Hospital's revenue per employee in the last FY averaged $47K, while opex per employee averaged $11K for the same period.
Mayapada Hospital's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mayapada Hospital's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Mayapada Hospital and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | 8% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $47K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 24% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mayapada Hospital acquired XXX companies to date.
Last acquisition by Mayapada Hospital was XXXXXXXX, XXXXX XXXXX XXXXXX . Mayapada Hospital acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Mayapada Hospital founded? | Mayapada Hospital was founded in 1991. |
Where is Mayapada Hospital headquartered? | Mayapada Hospital is headquartered in Indonesia. |
How many employees does Mayapada Hospital have? | As of today, Mayapada Hospital has 4.1K+ employees. |
Is Mayapada Hospital publicy listed? | Yes, Mayapada Hospital is a public company listed on IDX. |
What is the stock symbol of Mayapada Hospital? | Mayapada Hospital trades under SRAJ ticker. |
When did Mayapada Hospital go public? | Mayapada Hospital went public in 2011. |
Who are competitors of Mayapada Hospital? | Similar companies to Mayapada Hospital include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of Mayapada Hospital? | Mayapada Hospital's current market cap is $2.3B |
Is Mayapada Hospital profitable? | Yes, Mayapada Hospital is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.